The efficacy and safety of thalidomide in the treatment of refractory Crohn's disease in adults: a double-center, double-blind, randomized–controlled trial

BACKGROUND: Thalidomide is applied in therapy for refractory Crohn's disease (CD) in adults, but systematic and rigorous clinical evidence is scant. The aim was to provide theoretical references for the efficacy of thalidomide in the therapy for refractory CD in adults. METHODS: A double-center...

Descripción completa

Detalles Bibliográficos
Autores principales: Peng, Xiang, Lin, Zi-Wen, Zhang, Min, Yao, Jia-Yin, Zhao, Jun-Zhang, Hu, Pin-Jin, Cao, Qian, Zhi, Min
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9583847/
https://www.ncbi.nlm.nih.gov/pubmed/36284737
http://dx.doi.org/10.1093/gastro/goac052

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9583847/
https://www.ncbi.nlm.nih.gov/pubmed/36284737
http://dx.doi.org/10.1093/gastro/goac052

Ejemplares similares